Trials / Unknown
UnknownNCT00959205
The Efficacy and Safety of CARTO 3D Mapping System Versus Conventional Method in AF and VT
Phase Ⅳ Study of CARTO 3D Mapping System vs Conventional Method in AF & VT
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- Sponsor
- Korea University · Academic / Other
- Sex
- All
- Age
- 20 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of electroanatomic imaging compared to conventional method in patients with VT.
Detailed description
To evaluate the efficacy and safety of electroanatomic imaging (CARTO) compared to conventional fluoroscopically guided activation mapping (Conventional) method in patients with Atrial Fibrillation and Substrate-dependent Ventricular Tachycardia To evaluate cost-effectiveness of CARTO 3D image system compared to conventional method in the same study subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CARTO 3D | CARTO (3D Electroanatomic imaging) |
| DEVICE | Angiography | Conventional fluoroscopically guided activation mapping |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2010-06-01
- Completion
- 2011-02-01
- First posted
- 2009-08-14
- Last updated
- 2010-05-20
Locations
5 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00959205. Inclusion in this directory is not an endorsement.